SIBBORAN
Google image searchProduct monograph
Active ingredient
landiolol hydrochloride, 300 MG/VIAL
DIN: 02543338
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: TRIMEDIC THERAPEUTICS INC.
Date: 11-AUG-2024
ATC:
- C07 — BETA BLOCKING AGENTS (ATC, ATC/DDD, )
- C07A — BETA BLOCKING AGENTS (ATC, ATC/DDD)
- C07AB — Beta blocking agents, selective (ATC, ATC/DDD)
- C07AB14 — LANDIOLOL (ATC/DDD)
